Webdisclosure.com

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

25/10/2022 07:00

Relief Therapeutics Files Amendment No. 2 to its Form F-6 Registration Statement with the U.S. Securities and Exchange Commission

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

14/10/2022 07:00

Relief Therapeutics Announces Promotion of Paolo Galfetti to Chief Operating Officer

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

10/10/2022 07:00

Relief Announces U.S. Launch of PKU GOLIKE

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

06/10/2022 07:00

Relief Announces Exclusive Distributor for PKU GOLIKE in the U.S.

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

03/10/2022 07:00

Acer Therapeutics and Relief Therapeutics Announce Receipt of Notice of Allowance of US Patent Application Covering a Kit Comprising Phenylbutyrate and Sodium Benzoate

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

22/09/2022 07:00

Relief Therapeutics Announces IRB Approval and Initiation of an Investigator Initiated Trial of Nexodyn for Epidermolysis Bullosa at Ann & Robert H. Lurie Children's Hospital of Chicago

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

15/09/2022 07:00

Relief Reports Half-Year 2022 Results and Provides Corporate Update

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

12/09/2022 07:05

Relief Therapeutics to Participate in the 22nd Annual Biotech in Europe Forum

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

07/09/2022 07:00

Relief Therapeutics to Participate in the H.C. Wainwright 24th Annual Global Investment Conference

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

24/08/2022 07:00

Relief Therapeutics files registration statement on form F-1 with the U.S. Securities and Exchange Commission

Voir tous les communiqués de Relief Therapeutics Holdings AG

«
1
2
3
4
5
6
7
8
9
10